TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Gyre Therapeutics Reports Third Quarter 2025 and Year-to-Date Financial Results and Provides Business Update

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Gyre Therapeutics
Gyre Therapeutics Reports Third Quarter 2025 and Year-to-Date Financial Results and Provides Business Update

Gyre Therapeutics reported Q3 2025 net income of $5.9 million, with quarterly revenue of $30.6 million, up 20% year-over-year. The company revised full-year revenue guidance to $115-118 million due to delayed product rollouts and procurement uncertainties.

Insights
GOOGL   neutral

Mentioned as a client of NOMOBO, no direct impact from the acquisition


GYRE   neutral

Mixed financial performance with revenue growth but reduced annual guidance, indicating challenges in product commercialization